Calik, Michael W. http://orcid.org/0000-0001-6295-7420
Carley, David W.
Funding for this research was provided by:
National Institutes of Health (1UM1HL112856)
Article History
Received: 14 March 2023
Accepted: 20 July 2023
First Online: 28 July 2023
Declarations
:
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
: Not applicable.
: Michael W. Calik, PhD, has no conflicts of interest to disclose. David W. Carley, PhD, has conflicts of interest: stock/stockholder, royalties, and intellectual property rights from RespireRx (formerly Cortex Pharmaceuticals).